CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 536 of 1
Non-Antibody Products
Page 536 of 1,297
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| GSK3β (Phospho-Ser9) TR-FRET Assay Kit | This GSK3β (Phospho-Ser9) TR-FRET Assay Kit uses a homogeneous TR-FRE… | 9600 Well | 500251-9600WELLS | More Info |
| GSK3β (Total) and (Phospho-Ser9) TR-FRET Assay Kit | This GSK3β (Total) and GSK3β (Phospho-Ser9) TR-FRET Assay Kit us… | 480 Well | 500253-480WELLS | More Info |
| GSK3β (Total) TR-FRET Assay Kit | This GSK3β (Total) TR-FRET Assay Kit uses a homogeneous TR-FRET assay… | 2400 Well | 500252-2400WELLS | More Info |
| GSK3β (Total) TR-FRET Assay Kit | This GSK3β (Total) TR-FRET Assay Kit uses a homogeneous TR-FRET assay… | 480 Well | 500252-480WELLS | More Info |
| GSK3β (Total) TR-FRET Assay Kit | This GSK3β (Total) TR-FRET Assay Kit uses a homogeneous TR-FRET assay… | 4800 Well | 500252-4800WELLS | More Info |
| GSK3β (Total) TR-FRET Assay Kit | This GSK3β (Total) TR-FRET Assay Kit uses a homogeneous TR-FRET assay… | 96 Well | 500252-96WELLS | More Info |
| GSK3β (Total) TR-FRET Assay Kit | This GSK3β (Total) TR-FRET Assay Kit uses a homogeneous TR-FRET assay… | 9600 Well | 500252-9600WELLS | More Info |
| GSK106 (hydrochloride) | An inactive control for the selective PAD4 inhibitors, GSK484 and GSK199 (… | 1 mg | 17490-1 | More Info |
| GSK106 (hydrochloride) | An inactive control for the selective PAD4 inhibitors, GSK484 and GSK199 (… | 10 mg | 17490-10 | More Info |
| GSK106 (hydrochloride) | An inactive control for the selective PAD4 inhibitors, GSK484 and GSK199 (… | 5 mg | 17490-5 | More Info |
| GSK106 (hydrochloride) | An inactive control for the selective PAD4 inhibitors, GSK484 and GSK199 (… | 500 µg | 17490-500 | More Info |
| GSK3368715 (hydrochloride) | An inhibitor of type I PRMTs (IC50s = 3.1, 162, 38, 4.7, and 39 nM for PRM… | 1 mg | 34886-1 | More Info |
| GSK3368715 (hydrochloride) | An inhibitor of type I PRMTs (IC50s = 3.1, 162, 38, 4.7, and 39 nM for PRM… | 10 mg | 34886-10 | More Info |
| GSK3368715 (hydrochloride) | An inhibitor of type I PRMTs (IC50s = 3.1, 162, 38, 4.7, and 39 nM for PRM… | 5 mg | 34886-5 | More Info |
| GSK369796 (hydrochloride) | An antimalarial agent; active against the chloroquine-sensitive P. falcipa… | 1 mg | 36061-1 | More Info |
| GSK369796 (hydrochloride) | An antimalarial agent; active against the chloroquine-sensitive P. falcipa… | 10 mg | 36061-10 | More Info |
| GSK369796 (hydrochloride) | An antimalarial agent; active against the chloroquine-sensitive P. falcipa… | 25 mg | 36061-25 | More Info |
| GSK369796 (hydrochloride) | An antimalarial agent; active against the chloroquine-sensitive P. falcipa… | 5 mg | 36061-5 | More Info |
| GSK484 (hydrochloride) | A reversible inhibitor of PAD4 (IC50 = 50 nM) that binds to the low-calciu… | 1 mg | 17488-1 | More Info |
| GSK484 (hydrochloride) | A reversible inhibitor of PAD4 (IC50 = 50 nM) that binds to the low-calciu… | 10 mg | 17488-10 | More Info |
| GSK484 (hydrochloride) | A reversible inhibitor of PAD4 (IC50 = 50 nM) that binds to the low-calciu… | 5 mg | 17488-5 | More Info |
| GSK484 (hydrochloride) | A reversible inhibitor of PAD4 (IC50 = 50 nM) that binds to the low-calciu… | 500 µg | 17488-500 | More Info |
| GSK-J4 (hydrochloride) | An ethyl ester prodrug of the JMJD3 selective histone demethylase inhibito… | 10 mg | 12073-10 | More Info |
| GSK-J4 (hydrochloride) | An ethyl ester prodrug of the JMJD3 selective histone demethylase inhibito… | 25 mg | 12073-25 | More Info |
| GSK-J4 (hydrochloride) | An ethyl ester prodrug of the JMJD3 selective histone demethylase inhibito… | 5 mg | 12073-5 | More Info |
| GSK-J4 (hydrochloride) | An ethyl ester prodrug of the JMJD3 selective histone demethylase inhibito… | 50 mg | 12073-50 | More Info |
| GSK-J5 (hydrochloride) | A pyridine regio-isomer of the JMJD3 inhibitor GSK-J4; cell-permeable and… | 1 mg | 12074-1 | More Info |
| GSK-J5 (hydrochloride) | A pyridine regio-isomer of the JMJD3 inhibitor GSK-J4; cell-permeable and… | 10 mg | 12074-10 | More Info |
| GSK-J5 (hydrochloride) | A pyridine regio-isomer of the JMJD3 inhibitor GSK-J4; cell-permeable and… | 5 mg | 12074-5 | More Info |
| GSK-J5 (hydrochloride) | A pyridine regio-isomer of the JMJD3 inhibitor GSK-J4; cell-permeable and… | 50 mg | 12074-50 | More Info |
| GSK-J1 (sodium salt) | A potent, cell impermeable inhibitor of the H3K27 histone demethylases JMJ… | 1 mg | 12054-1 | More Info |
| GSK-J1 (sodium salt) | A potent, cell impermeable inhibitor of the H3K27 histone demethylases JMJ… | 10 mg | 12054-10 | More Info |
| GSK-J1 (sodium salt) | A potent, cell impermeable inhibitor of the H3K27 histone demethylases JMJ… | 5 mg | 12054-5 | More Info |
| GSK-J1 (sodium salt) | A potent, cell impermeable inhibitor of the H3K27 histone demethylases JMJ… | 50 mg | 12054-50 | More Info |
| GSK-J2 (sodium salt) | A negative control compound for GSK-J1 (IC50 = >100 µM for JMJD3) | 1 mg | 12056-1 | More Info |
| GSK-J2 (sodium salt) | A negative control compound for GSK-J1 (IC50 = >100 µM for JMJD3) | 10 mg | 12056-10 | More Info |
| GSK-J2 (sodium salt) | A negative control compound for GSK-J1 (IC50 = >100 µM for JMJD3) | 5 mg | 12056-5 | More Info |
| GSK-J2 (sodium salt) | A negative control compound for GSK-J1 (IC50 = >100 µM for JMJD3) | 50 mg | 12056-50 | More Info |
| GSK-LSD1 (hydrochloride) | An irreversible, mechanism-based inhibitor of LSD1 (IC50 = 16 nM); induces… | 1 mg | 16439-1 | More Info |
| GSK-LSD1 (hydrochloride) | An irreversible, mechanism-based inhibitor of LSD1 (IC50 = 16 nM); induces… | 10 mg | 16439-10 | More Info |
| GSK-LSD1 (hydrochloride) | An irreversible, mechanism-based inhibitor of LSD1 (IC50 = 16 nM); induces… | 25 mg | 16439-25 | More Info |
| GSK-LSD1 (hydrochloride) | An irreversible, mechanism-based inhibitor of LSD1 (IC50 = 16 nM); induces… | 5 mg | 16439-5 | More Info |
| GSK121 (trifluoroacetate salt) | The initial compound identified in a screen for PAD4 inhibitors (IC50 = 3.… | 1 mg | 17491-1 | More Info |
| GSK121 (trifluoroacetate salt) | The initial compound identified in a screen for PAD4 inhibitors (IC50 = 3.… | 10 mg | 17491-10 | More Info |
| GSK121 (trifluoroacetate salt) | The initial compound identified in a screen for PAD4 inhibitors (IC50 = 3.… | 5 mg | 17491-5 | More Info |
| GSK121 (trifluoroacetate salt) | The initial compound identified in a screen for PAD4 inhibitors (IC50 = 3.… | 500 µg | 17491-500 | More Info |
| G-418 (sulfate) | An aminoglycoside antibiotic; active against T. thermophila (IC50 = 10 &mi… | 1 g | 13200-1 | More Info |
| G-418 (sulfate) | An aminoglycoside antibiotic; active against T. thermophila (IC50 = 10 &mi… | 5 g | 13200-5 | More Info |
| GT 2016 | An antagonist of histamine H3 receptors (Ki = 43.8 nM); selective for H3 o… | 1 mg | 11996-1 | More Info |
| GT 2016 | An antagonist of histamine H3 receptors (Ki = 43.8 nM); selective for H3 o… | 10 mg | 11996-10 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile